Dyne Therapeutics, Inc. (DYN)
USD 9.1
(-8.22%)
USD 9.1
(-8.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 2.46 Million | 3.34 Million | 1.08 Million | 700 Thousand | 271 Thousand | 24 Thousand |
| Gross Profit | -2.46 Million | -3.34 Million | -1.08 Million | -700 Thousand | -271 Thousand | -24 Thousand |
| Operating Expenses | 242.16 Million | 170.96 Million | 150.02 Million | 58.64 Million | 13.82 Million | 4.79 Million |
| Selling, General and Administrative Expenses | 31.4 Million | 28.2 Million | 28.71 Million | 13.44 Million | 2.78 Million | 517 Thousand |
| Research and Development Expenses | 210.76 Million | 142.76 Million | 121.3 Million | 45.2 Million | 11.04 Million | 4.27 Million |
| Other Expenses | - | 2.86 Million | -8000.00 | -790 Thousand | -1.32 Million | -21 Thousand |
| Cost and Expenses | 242.16 Million | 170.96 Million | 150.02 Million | 58.64 Million | 13.82 Million | 4.79 Million |
| Operating Income | -242.16 Million | -170.96 Million | -150.02 Million | -58.64 Million | -13.82 Million | -4.79 Million |
| Interest Expense | - | 2.91 Million | - | 396 Thousand | - | 5000.00 |
| Income Tax Expense | - | -2.86 Million | -8000.00 | -700 Thousand | -1.32 Million | -11 Thousand |
| Earnings before Tax | -235.93 Million | -168.09 Million | -149.29 Million | -59.43 Million | -14.85 Million | -4.81 Million |
| Net Income | -235.93 Million | -165.23 Million | -149.28 Million | -58.73 Million | -13.53 Million | -4.81 Million |
| Earnings Per Share Basic | -3.95 | -3.18 | -2.93 | -4.08 | -0.30 | -0.47 |
| Earnings Per Share Diluted | -3.95 | -3.18 | -2.93 | -4.08 | -0.30 | -0.47 |
| Weighted Average Shares Outstanding | 59.68 Million | 51.97 Million | 50.89 Million | 14.39 Million | 45.42 Million | 10.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 59.68 Million | 51.97 Million | 50.89 Million | 14.39 Million | 45.42 Million | 10.32 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -233.47 Million | -164.75 Million | -148.2 Million | -58.34 Million | -14.58 Million | -4.78 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 3.78 Million | - | - |
| Cost of Revenue | 400 Thousand | 386 Thousand | 2.46 Million | 567 Thousand | 597 Thousand | 674 Thousand |
| Gross Profit | -400 Thousand | -386 Thousand | -2.46 Million | 3.22 Million | -597 Thousand | -674 Thousand |
| Operating Expenses | 71.56 Million | 69.15 Million | 239.7 Million | 67.12 Million | 62.27 Million | 66.73 Million |
| Selling, General and Administrative Expenses | 9.29 Million | 24.61 Million | - | 8.27 Million | 7.02 Million | 7.6 Million |
| Research and Development Expenses | 62.26 Million | 44.53 Million | - | 58.84 Million | 55.25 Million | 59.13 Million |
| Other Expenses | -192 Thousand | 506 Thousand | - | -701 Thousand | 2.06 Million | -373 Thousand |
| Cost and Expenses | 71.96 Million | 69.15 Million | 242.16 Million | 67.68 Million | 62.27 Million | 66.73 Million |
| Operating Income | -71.96 Million | -69.15 Million | -242.16 Million | -67.68 Million | -62.27 Million | -66.73 Million |
| Interest Expense | - | - | - | 1.68 Million | - | - |
| Income Tax Expense | -1.00 | -3 Million | - | 4.32 Million | -431 Thousand | -2.2 Million |
| Earnings before Tax | -65.1 Million | -65.64 Million | -235.93 Million | -66.63 Million | -60.21 Million | -64.9 Million |
| Net Income | -65.1 Million | -65.64 Million | -235.93 Million | -66.63 Million | -60.21 Million | -64.9 Million |
| Earnings Per Share Basic | -0.70 | -0.81 | - | -1.09 | -0.99 | -1.08 |
| Earnings Per Share Diluted | -0.70 | -0.81 | - | -1.09 | -0.99 | -1.08 |
| Weighted Average Shares Outstanding | 92.5 Million | 81.04 Million | 59.68 Million | 61.39 Million | 61.1 Million | 59.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 92.5 Million | 81.04 Million | 59.68 Million | 61.39 Million | 61.1 Million | 59.83 Million |
| Gross Margin | - | - | - | 0.85 | - | - |
| EBIT Margin | - | - | - | -17.72 | - | - |
| Profit Margin | - | - | - | -17.59 | - | - |
| EBITDA | -71.56 Million | -68.77 Million | - | -67.12 Million | -62.27 Million | -66.3 Million |
| Earnings Before Tax Margin | - | - | - | -17.87 | - | - |
AGSTRA
NVDA
TEXMOPIPES
ICM
PAVMZ
LILA